B, M. C. d. (2005). Ciprofibrate diminishes non-hdlc and improves hdlc in patients with frederickson type iv dyslipidemia phenotype. Sociedad Venezolana de Farmacología Clínica y Terapéutica.
Citazione stile Chigago Style (17a edizione)B, M. Cabrera de. Ciprofibrate Diminishes Non-hdlc and Improves Hdlc in Patients with Frederickson Type Iv Dyslipidemia Phenotype. Sociedad Venezolana de Farmacología Clínica y Terapéutica, 2005.
Citatione MLA (9a ed.)B, M. Cabrera de. Ciprofibrate Diminishes Non-hdlc and Improves Hdlc in Patients with Frederickson Type Iv Dyslipidemia Phenotype. Sociedad Venezolana de Farmacología Clínica y Terapéutica, 2005.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.